BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19075628)

  • 1. Strategies for targeting lentiviral vectors.
    Frecha C; Szécsi J; Cosset FL; Verhoeyen E
    Curr Gene Ther; 2008 Dec; 8(6):449-60. PubMed ID: 19075628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vectors for immune cells targeting.
    Froelich S; Tai A; Wang P
    Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):208-18. PubMed ID: 20085508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-engineering of lentiviral vectors.
    Verhoeyen E; Cosset FL
    J Gene Med; 2004 Feb; 6 Suppl 1():S83-94. PubMed ID: 14978753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
    Bartosch B; Cosset FL
    Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1-based lentiviral vectors.
    Liu YP; Berkhout B
    Methods Mol Biol; 2014; 1087():273-84. PubMed ID: 24158830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy Applications of Non-Human Lentiviral Vectors.
    Munis AM
    Viruses; 2020 Sep; 12(10):. PubMed ID: 33003635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
    Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
    Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter.
    Kamata M; Liu S; Liang M; Nagaoka Y; Chen IS
    Hum Gene Ther; 2010 Nov; 21(11):1555-67. PubMed ID: 20524893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.
    Mitta B; Rimann M; Ehrengruber MU; Ehrbar M; Djonov V; Kelm J; Fussenegger M
    Nucleic Acids Res; 2002 Nov; 30(21):e113. PubMed ID: 12409472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of targeting performance of oncoretroviral versus lentiviral vectors on human keratinocytes.
    Serrano F; Del Rio M; Larcher F; Garcia M; Muñoz E; Escamez MJ; Muñoz M; Meana A; Bernad A; Jorcano JL
    Hum Gene Ther; 2003 Nov; 14(16):1579-85. PubMed ID: 14577919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
    Zhou X; Cui Y; Huang X; Yu Z; Thomas AM; Ye Z; Pardoll DM; Jaffee EM; Cheng L
    Hum Gene Ther; 2003 Jul; 14(11):1089-105. PubMed ID: 12885348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
    Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction.
    Page A; Fusil F; Cosset FL
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.
    Greenberg KP; Geller SF; Schaffer DV; Flannery JG
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1844-52. PubMed ID: 17389520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in lentiviral vectors: a patent review.
    Picanco-Castro V; de Sousa Russo-Carbolante EM; Tadeu Covas D
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):82-90. PubMed ID: 22670608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells.
    Zhang XY; La Russa VF; Bao L; Kolls J; Schwarzenberger P; Reiser J
    Mol Ther; 2002 May; 5(5 Pt 1):555-65. PubMed ID: 11991746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
    Mitta B; Weber CC; Rimann M; Fussenegger M
    Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
    Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
    Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
    Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
    J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-integrating lentiviral vectors.
    Sarkis C; Philippe S; Mallet J; Serguera C
    Curr Gene Ther; 2008 Dec; 8(6):430-7. PubMed ID: 19075626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.